Solving Cold Chain Issues
for Emerging Biopharma
Helping emerging biopharmaceutical companies navigate global regulatory guidelines and tackle cold chain challenges.LET'S TALK
Cold Chain Challenges for Emerging Biopharma
Whether you develop CAR-T cell therapies, biologics, or other advanced therapies, you’re focused on innovating to bring new clinical trial candidates to market and address unmet medical needs. Companies like yours represent a growing share of the innovation landscape. And with one or more clinical trial candidates in the pipeline, you need to optimize your return on investment. As you build out your in-house staffing, facilities, andcapabilities, a strong network of experienced consultants and contractors can help you reach your goals and put your funding to best use.
Global regulatory guidelines for pharmaceutical cold chain therapies are confusing, complex, and difficult to navigate. Even the most innovative emerging biopharmas typically don’t have the in-house engineering resources, regulatory expertise, or pharmaceutical cold chain filing know-how to tackle these challenges alone. And without easy access to our unique transport simulation technology or deep domain expertise available 24/7, it can be tough to meet complicated requirements and get to market fast.
How Modality Solutions Can Help
Modality Solutions combines all the expertise and experience emerging biopharmas need to achieve your goal and ours: the successful, rapid approval of your therapy. Our end-to-end solution spots issues early in your clinical development cycle—avoiding approval delays, reducing costs, and ensuring successful validation for a timely filing.
We’ve navigated the complexities of NDA and BLA filing for many emerging biopharmas,applying our unrivaled regulatory expertise and biopharma supply chain experience to guide you to filing success.
Case StudiesView All Case Studies
Morphosys Case Study:
How Robust Validation Planning and Transport Simulation Aided Accelerated Approval for MONJUVI™
When MorphoSys obtained Fast Track designation for MONJUVI, a monoclonal antibody treatment for lymphoma, establishing a robust pharmaceutical supply chain was key to gaining commercial..View the case study now
Atara Biotherapeutics Case Study:
Using Robust Cold Chain Validation to Support CAR-T Therapy Filing
Concerned about vial breakage when transporting its CAR-T therapy on pallets, Atara Biotherapeutics sought to improve the frozen logistics process and support the move to a refrigerated formulation in Phase II...View the case study now
Immunomedics Case Study:
How Transport Simulation Helped This ADC Therapy Achieve Fast Track Approval
TRODELVY™ represented a promising antibody-drug conjugate therapy for triple negative breast cancer, but filing obstacles threatened its commercialization. Immunomedics tapped Modality Solutions to...View the case study now
for Emerging Biopharma
Modality Solutions provides the solutions proven to help biopharmaceutical innovators address cold chain challenges and obtain fast therapy approval.
We help prepare you for a successful regulatory filing every step of the way—assessing your cold chain, drug stability, packaging, and third-party logistics qualifications; developing a validation master plan; conducting transport simulation testing; and preparing your team for the Common Technical Document (CTD) submission and pre-approval inspection.Learn More
Whether you need turnkey support or you want to augment your in-house resources, our customizable Transport Simulation Solutions can deliver the robust data regulators expect during your drug’s review and approval. We assess transport risks, develop validation master plans, and rigorously test drug formulations and packaging for the five hazards that can occur in transport—concurrently and at the edges of the supply chain’s operating space—through our ISO-certified Advantage Transport Simulation Laboratory™.Learn More
When you’re preparing for a new filing, responding to an Information Request, or looking to improve the supply chain for a commercial product, our Engineering Consulting Solutions are invaluable. Our cold chain subject matter experts draw on their extensive experience to help you overcome complex supply chain challenges, reduce risk, and meet regulatory requirements at every phase.Learn More
Modality Solutions can conduct rigorous, comprehensive testing of your therapeutic against a wide range of ASTM and ISTA standards at our independent Advantage Transport Simulation LaboratoryTM or a third-party lab—ranging from plunger movement studies to confirm sterility and efficacy, to drug-device functionality testing, and many other applications.Learn More
Cold Chain Optimization
Cold Chain Optimization
We protect your finished drugs and materials, minimize your risks, and reduce your total delivered costs through our Cold Chain Optimization Solutions. These customized services include cold chain monitoring and control optimization, supplier agreement review/development, and a unique AI-driven shipper selection service that translates weather data into the inside temperature of a thermal shipper—enabling you to choose the container with the best cost/risk ratio.Learn More
Did You Know?
Emerging Biopharmas drove:
Original patents for 29 of the current top 100 drugs, accounting for 40% of US pharmaceutical sales in 2018
65% of all clinical trials conducted in 2018
58% of completed clinical trials (among those with a pharma sponsor)
90+% of next generation biotherapies, including cell and gene therapies and RNAi technologies
What Our Clients Say
“We are very delighted to inform you the FDA has approved tafasitamab. On behalf of the whole team, we want to thank you for your great support. Well done! “
Ready to discuss cold chain needs Let's Start a Conversation
for your new biopharmaceutical?
Related InsightsView All Resources
Ship, Quarantine, or Discard: A Streamlined Process and Analytical Tool Yields Better Decisions on Resolving Temperature Excursions
It’s estimated that seven out of ten pharmaceutical products in the US require temperature...read Details
Why Cold Chain Engineering is Vital to Transporting Monoclonal Antibodies (mAbs) and Other Biologics
The global biologics market is forecast to reach $625 million by 20261, fueled by...read Details
Modality Solutions Welcomes Sumika Stansbury to its Growing Cold Chain Engineering™ Team
September 9, 2021: Modality Solutions announced that Sumika Stansbury has joined the company as...read Details